Status:
COMPLETED
D-serine for Posttraumatic Stress Disorder Treatment
Lead Sponsor:
Herzog Hospital
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
25-75 years
Phase:
PHASE2
Brief Summary
The aim of this study is to asses the effects of the NMDA receptor full agonist D-serine while used as adjuvant treatment for individuals suffering from chronic posttraumatic stress disorder (PTSD). D...
Eligibility Criteria
Inclusion
- • Chronic PTSD (DSM-IV diagnosis)
Exclusion
- Other psychiatric diagnosis
- Substance abuse
- Unstable medical condition
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00215878
Start Date
August 1 2003
End Date
May 1 2008
Last Update
July 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ezrat Nashim-Herzog Memorial Hospital
Jerusalem, Israel, 91351